Jon Fryzek, PhD, MPH

Principal Epidemiologist Practice Director
EpidStrategies, A Division of ToxStrategies, Inc.

Poster(s):

• (1636) Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a disproportionate benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET